GlassScriptPhysician profile
Samuel K Cho
NPI 1538318209
$320,217.15
in general payments reported to CMS, 2019-2025
24 companies · $86K in 2025
The $86K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53K · 2020: $8,672 · 2021: $42K · 2022: $45K · 2023: $33K · 2024: $54K · 2025: $86K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $64K · Consulting Fee: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $32K · Travel and Lodging: $31K · Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $64,399.21 |
| Consulting Fee | $35,101.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,762.50 |
| Travel and Lodging | $30,778.36 |
| Food and Beverage | $10,439.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $93,793.73 | 2019-2025 | Resonate, Xlif, Reline |
| Alphatec Spine, INC | $51,371.16 | 2022-2025 | Other - Miscellaneous, Identiti, Novel |
| Stryker Corporation | $47,791.85 | 2019-2025 | N/A, Everest Spinal System |
| Zimmer Biomet Holdings, INC. | $31,359.10 | 2019 | |
| Si-Bone, INC. | $30,824.71 | 2022-2025 | |
| Medtronic, INC. | $27,943.17 | 2021-2025 | Cd Horizon Spinal System, Catalyft Pl Expandable Interbody System, Stealthstation S8 Platform |
| Amplify Surgical, INC. | $17,278.32 | 2021-2025 | Dualx and Dualportal, Dualx and Dual Portal, Dualx and Dualportal |
| Cerapedics INC. | $7,864.36 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Nuvasive, INC. | $3,839.09 | 2019-2023 | Reline, Versatie |
| Synthes Gmbh | $3,592.31 | 2021-2024 | |
| Ctl Medical Corporation | $1,721.40 | 2019-2022 | |
| Depuy Synthes Sales INC. | $437.66 | 2023-2025 | Teligen, Conduit, Fibergraft Bg Morsels |
| Medicrea USA, Corp. | $399.67 | 2019 | |
| Integrity Implants INC. | $375.17 | 2021 | |
| Spinal Elements, INC. | $313.71 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $257.28 | 2021-2022 | |
| Orthofix Medical, INC. | $250.77 | 2020-2025 | Cervical-Stim, Spinal-Stim, Spinal-Stim |
| Gs Solutions, INC. | $203.09 | 2023-2025 | |
| Medtronic USA, INC. | $198.02 | 2020 | |
| Theragen, INC. | $150.00 | 2023 | Actastim-S |
| Zimvie INC. | $140.26 | 2023 | |
| Augmedics INC. | $61.50 | 2020 | |
| Highridge Medical LLC | $35.42 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Redhill Biopharma INC. | $15.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$220,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.